131 Iodine MIBG Therapy For Pediatric Neuroblastoma
The Nuclear Medicine Therapy CentreatFortisMemorialResearchInstitute(FMRI)isthe OnlyCentreinIndiaOfferingMyeloblativeMIBGTherapyforHighRiskNeuroblastomasin Children.
MIBGTherapyhasbeenextensivelyusedtotreatpatientswithadvancedneuroblastomas–a largestudyhasshownthatabout30-40%ofchildrenwithrelapsedneuroblastomahave respondedtoMIBGTherapy,andthismakesitoneofthemostactiveagentsforrelapsed disease.Whilethistherapydoesnotcureneuroblastoma, I-131 MIBG Therapy allowspatients totakecontroloftheirdiseasetherebyprovidingthepossibilityofprolongeddisease stabilisation.